AstraZeneca (United States)

AstraZeneca is a global biopharmaceutical company headquartered in Cambridge, UK, with major US operations in Wilmington, Delaware. The company develops breakthrough medicines in oncology, cardiovascular, renal, metabolism, respiratory, and immunology. Key products include Tagrisso (osimertinib) for lung cancer, Lynparza (olaparib) for BRCA-mutated cancers, Farxiga (dapagliflozin) for diabetes and heart failure, Symbicort for asthma and COPD, and COVID-19 vaccines. AstraZeneca’s research-driven approach delivers innovative therapies that transform patient outcomes.